Fluorouracil

DB00544
Approved Indication

For the topical treatment of multiple actinic or solar keratoses. In the 5% strength it is also useful in the treatment of superficial basal cell carcinomas when conventional methods are impractical, such as with multiple lesions or difficult treatment sites. Fluorouracil injection is indicated in t

1 Targets
0 Resistance Mutations
2 References
3D Structure No structure available
No co-crystal structure available
Protein Targets
Mechanism of Action

The precise mechanism of action has not been fully determined, but the main mechanism of fluorouracil is thought to be the binding of the deoxyribonucleotide of the drug (FdUMP) and the folate cofactor, N5–10-methylenetetrahydrofolate, to thymidylate synthase (TS) to form a covalently bound ternary complex. This results in the inhibition of the formation of thymidylate from uracil, which leads to the inhibition of DNA and RNA synthesis and cell death. Fluorouracil can also be incorporated into RNA in place of uridine triphosphate (UTP), producing a fraudulent RNA and interfering with RNA processing and protein synthesis.

Details
DrugBank ID DB00544 ↗
Approval Date 1970-07-29
Molecular Weight 130.0772 g/mol
Drug Class Other
ATC Codes L01BC02, L01BC52
Synonyms 5-Fluoracil, 5-Fluoropyrimidine-2,4-dione, 5-Fluorouracil
SMILES
FC1=CNC(=O)NC1=O
ADMET Profile
Computing properties…
Drug References (DrugBank)